Sage Journals: Discover world-class research

Abstract

This paper provides an overview of the role of the sponsor in supporting and improving quality in the conduct of a trial through improved performance at the site. Critical issues reside in ensuring standardization of performance at all sites, hence homogeneous and unbiased results. Sponsor responsibilities in this process mainly include preparation of a feasible protocol, care in ensuring that personnel are qualified and trained, providing a communication and information network, and definition and enforcement of standards. A leading function is played by study monitors whose role is evolving into process-managers who are no longer confined to data verification. In such a context, the monitor's careful analysis of microactivities at the site substantially facilitates implementation of a system aimed at preventing performance deficiencies and delays.

A key to success is commitment to the project by all involved parties, not only the company and the investigator, but also hospital staff, monitors, clinical research organization (CRO) personnel, and patients. The sponsor's support in organizing and coordinating teams with different levels of responsibility, either managerial or operational, facilitates harmonized behavior, integrated communications, recognition of each member's role, and ultimately improved global performance and quality.

Keywords

Quality Clinical trial Sponsor

Get full access to this article

View all access options for this article.

References

Tabusso

Quality education: Regulatory aspects in the pharmaceutical industry. Drug Inf J. 1995;29: 1275–1283.

Barton

International Conference on Harmonization—Good Clinical Practices update. Drug Inf J. 1998;32:1143–1147.

Donahue

RMJ

Ruberg

Standardizing clinical study designs for accelerating drug development. Drug Inf J. 1997;31:655–663.

Olson

Shapiro

Introduction to improving clinical trials: Contemporary design solutions including endpoints, surrogate comparators, project planning, and computer-assisted trial design (CATD). Drug Inf J. 1998;32:955–956.

McFarland

Optimizing clinical site selection. Drug Inf J. 1996;30:793–798.

Case

The structure of high-performing project management organizations. Drug Inf J. 1998;32: 577–607.

Meimei

Ma J

Schlotzhauer

Using programming and database standards to promote efficiency. Drug Inf J. 1998;32:897–904.

Schoichet

Creasey

Kasay

A systems infrastructure for sponsor/CRO collaboration on international clinical trials. Drug Inf J. 1998;32:155–161.

Christiansen

Sundin

A data model for clinical study status reports. Drug Inf J. 1998;32:887–895.

10.

Johnson

SCD

The role of simulation in the management of research: What can the pharmaceutical industry learn from the aerospace industry?

Drug Inf J. 1998;32:961–969.

11.

Owen

The role and responsibilities of the investigator in ensuring quality laboratory data. Drug Inf J. 1997;31:723–727.

Clinical Study Preparation: Sponsor Support for the Quality of Site Management

Abstract

Keywords

Get full access to this article

References